We also use technology, including lab management software and hardware, to make compliance easier and part of our everyday lives.
CIM: How do you plan on attracting cultivators? How do you plan on getting your product to the market?
CN: To date, all of our customers and prospects have come to us through existing relationships. In California alone we have interest and/or LOI’s in place for we’ll over half of our 2020 production. As the facility ramps ups through Q1 of next year, I expect we will be completely spoken for in terms of our (significant) California production capacity.
CIM: Are you seeing price contraction in the market? How do you plan on maintaining and increasing margins?
CN: We have made significant investments in the newest lab production technology that will allow us to put out a far more consistent product at a price point that cultivators won’t be able to pass up - as I noted, this is because it is at or below what even the biggest cultivators can do in-house. A cultivator that is experiencing price compression will be able to make up some margin and revenue by using our products. As to Conception’s margins, we leverage scale and a variety of products at different price points, including, standard, “workhorse” genetics to more customized strains.
Email: [email protected]